HK Stock MarketDetailed Quotes

02181 MABPHARM-B

Watchlist
  • 0.330
  • +0.005+1.54%
Market Closed Nov 29 16:08 CST
1.36BMarket Cap-6000P/E (TTM)

MABPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CNY
2024/H1
Stock NameRevenueRatio
Drug sales income98.53M90.83%
中国内地独家推广许可权收入9.95M9.17%
Product

No Data

Region Currency:CNY
2024/H1
Stock NameRevenueRatio
The mainland of China108.48M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data